Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE001543 |
ID: | TCMBANKHE001543 |
药用植物名: | 北刘寄奴 |
治疗类型: | 活血祛瘀药 |
TCM_ID_id: | 1889 |
SymMap_id: | 39 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN002281 | eupatorin | MolPort-001-742-461; 6-methoxyluteolin-4'',7-dimethyl ether; KBioSS_001517; SCHEMBL555597; EUPATORIN; 3J474AV6MY; Flavone, 3',5-dihydroxy-4',6,7-trimethoxy-; A1-01414; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxychromen-4-one; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,7-dimethoxy-chromen-4-one; HMS3262O20; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-; KBio1_001963; MCULE-7438854859; ST50331588; AX8082670; SPBio_000532; KBio2_006653; Kinome_3214; Spectrum4_001833; AC1Q6AIH; ZINC1412; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4-chromenone; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-chromen-4-one; AKOS015856247; 3'',5-dihydroxy-4'',6,7-trimethoxy flavone; Flavone, 3',5-dihydroxy-4',6,7-trimethoxy- (8CI); ZB000328; NSC 106402; KBio2_001517; KBio2_004085; Spectrum2_000456; 3',6,7-trimethoxyflavone; KLAOKWJLUQKWIF-UHFFFAOYSA-N; 855-96-9; NSC106402; AC1L3Y1I; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4h-chromen-4-on; 6-Methoxyluteolin 4',7-dimethyl ether; W1625; Eupatorine; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one; 5,3'-Dihydroxy-6,7,4'-trimethoxyflavone; 3,5-dihydroxy-4,6,7-trimethoxyflavone; UNII-3J474AV6MY; DTXSID20234704; ST5331588; LMPK12111239; BDBM50344054; KBioGR_002532; MFCD00016929; FT-0614615; ACon1_001351; I14-111109; TR-026736; AK112334; NCGC00180598-01; 3'',5-DIHYDROXY-4'',6,7-TRIMETHOXYFLAVONE; 6-Methoxyluteolin 4 inverted exclamation marka,7-dimethyl ether; CHEBI:136666; AJ-08019; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy- (9CI); ST24044768; Eupatorin, >=97% (HPLC); ZINC00001412; Eupatorin, analytical standard; CTK8D4716; DivK1c_007019; 4H-1-Benzopyran-4-one,7-dimethoxy-; Flavone,5-dihydroxy-4',6,7-trimethoxy-; NCGC00261484-01; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,7-dimethoxy-chromone; CHEMBL487402; 4CN-1494; C-57546; SpecPlus_000923; Spectrum_001037; CCG-38698; 3',5-Dihydroxy-4',6,7-trimethoxyflavone; 3 inverted exclamation marka,5-Dihydroxy-4 inverted exclamation marka,6,7-trimethoxyflavone; Tox21_500799; Eupatorin; Spectrum5_000625 | C18H16O7 | 344.3 g/mol | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)O |
| TCMBANKIN004033 | ()-Nootkatone | ZINC01081321; (4R,4aS,6R)-6-isopropenyl-4,4a-dimethyl-3,4,5,6,7,8-hexahydronaphthalen-2-one; 74437_FLUKA; BB_NC-1524; (4R,4aS,6R)-4,4a-dimethyl-6-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one; 93785_FLUKA | C15H22O | 218.33 | |
| TCMBANKIN008604 | (2R)-3-(phenoxy)propane-1,2-diol | ZINC00409168 | C9H12O3 | 168.19 | |
| TCMBANKIN008887 | d-isomenthone | EINECS 214-813-5; (2R,5R)-2-isopropyl-5-methyl-1-cyclohexanone; Cyclohexanone, 5-methyl-2-(1-methylethyl)-, (2R-cis)-; (2R,5R)-5-methyl-2-propan-2-yl-cyclohexan-1-one; (2R,5R)-2-isopropyl-5-methylcyclohexanone; 18309-28-9; 1196-31-2; (2R,5R)-2-isopropyl-5-methyl-cyclohexan-1-one; (2R-cis)-5-methyl-2-(1-methylethyl)cyclohexanone; ZINC03860577; (+)-Isomenthone; (1R,4R)-p-menthan-3-one; EINECS 242-194-1; C11952; LMPR01020096; (2R,5R)-5-methyl-2-propan-2-ylcyclohexan-1-one; (2R,5R)-5-methyl-2-(propan-2-yl)cyclohexanone; CHEBI:36492; (2S-cis)-2-(Isopropyl)-5-methylcyclohexan-1-one | C10H18O | 154.25 | CC1CCC(C(=O)C1)C(C)C |
| TCMBANKIN010903 | (S)-Matsutake alcohol | ZINC02026960; (S)-1-Octen-3-ol; (S)-oct-1-en-3-ol; (3S)-oct-1-en-3-ol; CHEBI:46735; 3OL; 40577_FLUKA | C8H16O | 128.21 | CCCCCC(C=C)O |
| TCMBANKIN011258 | Pentatriacontane | pentatriacontane; 630-07-9; NSC125400; Pentatriacontane (8CI)(9CI); NSC 125400; N-PENTATRIACONTANE; 76968_FLUKA | C35H72 | 492.95 | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC |
| TCMBANKIN013688 | 3-hydroxy-2-(2-methylcyclohex-1-enyl)propionaldehyde | C10H16O2 | 168.23 g/mol | CC1=C(CCCC1)C(CO)C=O | |
| TCMBANKIN013721 | ZINC02042359 | (6R)-6,10-dimethylundecan-2-one | C13H26O | 198.34 | CC(C)CCCC(C)CCCC(=O)C |
| TCMBANKIN021929 | (1S,2S,5S)-2-isopropyl-5-methyl-1-cyclohexanol | (1S,2S,5S)-5-methyl-2-propan-2-yl-cyclohexan-1-ol; ZINC02038603; (1S,2S,5S)-5-methyl-2-propan-2-ylcyclohexan-1-ol; (1S,2S,5S)-2-isopropyl-5-methyl-cyclohexan-1-ol | C10H20O | 156.27 | |
| TCMBANKIN023721 | amylcyclopropane | Pentane, 1-cyclopropyl-; 2511-91-3; pentylcyclopropane; InChI=1/C8H16/c1-2-3-4-5-8-6-7-8/h8H,2-7H2,1H; 1-Cyclopropylpentane; Cyclopropane, pentyl- | C8H16 | 112.21 | CCCCCC1CC1 |
| TCMBANKIN023955 | ZINC02011663 | (3R)-octan-3-ol | C8H18O | 130.23 | CCCCCC(CC)O |
| TCMBANKIN026812 | (S)-4-Nonanolide | 104-61-0; (5S)-5-pentyloxolan-2-one; gamma-Nonalactone; (5S)-5-pentyltetrahydrofuran-2-one; Dihydro-5-pentyl-2(3H)-furanone; 74314_FLUKA; (5S)-5-amyltetrahydrofuran-2-one; C08501; (S)-gamma-Pentyl-gamma-butyrolactone; (S)-Dihydro-5-pentyl-2(3H)-furanone; (5S)-5-pentyl-2-tetrahydrofuranone | C9H16O2 | 156.22 | CCCCCC1CCC(=O)O1 |
| TCMBANKIN030787 | ascaridole | C10H16O2 | 168.23 | CC(C)C12CCC(C=C1)(OO2)C | |
| TCMBANKIN032653 | Guaiol | Spectrum3_001870; Guai-1(5)-en-11-ol; NSC19941; SCHEMBL18965701; C09676; 489-86-1; 448575_ALDRICH; Guaiac alcohol; 5-Azulenemethanol, 1,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.,3,8-tetramethyl-, [3S-(3.alpha.,5.alpha.,8.alpha.)]-; 2-[(3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl]propan-2-ol; 38730A; Champacol; [3S-(3alpha,5alpha,8alpha)]-1,2,3,4,5,6,7,8-octahydro-alpha,alpha,3,8-tetramethyl-5-azulenemethanol; (−)-Guaiol; CHEBI:5552; BSPBio_003320; guaiol; 50900_FLUKA; 29242_FLUKA; SPECTRUM1800009; (3R,6S,10S)-6,10,alpha,alpha-Tetramethylbicyclo[5.3.0]dec-1(7)-ene-3-methanol; Champaca camphor; KBio3_002822 | C15H26O | 222.37 | CC1CCC(CC2=C1CCC2C)C(C)(C)O |
| TCMBANKIN033905 | Ermanin | 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)-; MEGxp0_000250; 5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)chromen-4-one; ZINC01664047; 5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)-4-chromenone; AIDS-001405; 5,7-Dihydroxy-3,4'-dimethoxyflavone; 5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)chromone; AIDS001405; 5,7-Dihydroxy-3-methoxy-2-(4-methoxyphenyl)-4-benzopyrone; Kaempferol-3,4'-dimethylether; NSC31882; 20869-95-8; Chrysin, 3,4'-dimethoxy-; EINECS 244-093-8; NCI60_002742; NSC 31882; 3,4'-Dimethoxychrysin | C17H14O6 | 314.29 | COC1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC |
| TCMBANKIN034376 | 3-methyl-bycyclo[2.2.2.]octanone | C9H14O | 138.21 | ||
| TCMBANKIN036917 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN037308 | β-Eudesmol | 2-Naphthaleneethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-; SCHEMBL12633040; beta-eudesmol; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-decalin-2-yl]propan-2-ol; 17790_FLUKA; 2-Naphthalenemethanol, decahydro-8-methylene-alpha,alpha,4a-trimethyl-, (2R-(2-alpha,4a-alpha,8a-beta)-; 2-[(2R,4aR,8aS)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; 3beta-(1-Hydroxy-1-methylethyl)-5-methylene-8abeta-methyldecahydronaphthalene; Beta- Eudesmol; (2R,4aR,8aS)-Decahydro-8-methylene-alpha,alpha,4a-trimethyl-2-naphthylmethanol; β- eudesmol; Eudesm-4(14)-en-11-ol (8CI); beta-Selinenol; rel-2-[(2R,4aR,8aS)-4a-methyl-8-methylenedecahydronaphthalen-2-yl]propan-2-ol; 2-naphthalenemethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-, (2R,4aR,8aS)-; C09664; InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12-13,16H,1,5-10H2,2-4H3/t12-,13+,15-/m1/s; beta-eudesmol ; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-2-decalinyl]propan-2-ol; AC1NSVC6; 2-[(2R,4aR)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; beta-Eudesmol; beta- eudesmol; 473-15-4; 4(15)-eudesmen-11-ol | 222.37 | ||
| TCMBANKIN039345 | LOLIOLIDE | (6S,7aR)-6-hydroxy-4,4,7a-trimethyl-6,7-dihydro-5H-1-benzofuran-2-one; 1,3-Dihydroxy-3,5,5-trimethylcyclohexylidene-4-acetic acid lactone; (6S,7aR)-6-hydroxy-4,4,7a-trimethyl-6,7-dihydro-5H-benzofuran-2-one; loliolide; 11028-27-6; 2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-6-hydroxy-4,4,7a-trimethyl-, (6S-cis)-; NSC 289632 | C11H16O3 | 196.24 | CC1(CC(CC2(C1=CC(=O)O2)C)O)C |
| TCMBANKIN039554 | hexanoic acid | (C6-C12) Alkylcarboxylic acid; n-Hexoic acid; BRN 0773837; Hexanoyl DL-carnitine; AC1O52RE; hexanoicacid; 142-62-1; Hexanoic acid (natural); n-Hexanoic acid; CCRIS 1347; Hexacid 698; 153745_ALDRICH; Hexanoic acid; 13476-79-4; 8040-17-3; 51109-46-7; AI3-07701; WLN: QV5; VVPRQWTYSNDTEA-UHFFFAOYSA-N; 19455-00-6; (C5-C9) Monobasic acids; Pentylformic acid; Hexanoyl-d,l-carnitine; Capronic acid; Butylacetic acid; Kyselina kapronova [Czech]; 4-02-00-00917 (Beilstein Handbook Reference); C01585; 1-Pentanecarboxylic acid; UN2829; 3-hexanoyloxy-4-(trimethylazaniumyl)butanoate; Fatty acids, C6-12; (C6-C12)Alkylcarboxylic acid; W255912_ALDRICH; NSC8266; CAPROIC ACID; CH3-[CH2]4-COOH; LMFA01010006; HEXANOIC ACID (CAPROIC ACID); n-Caproic acid; EINECS 267-013-3; CHEBI:30776; Hexanoylcarnitine; 68603-84-9; 70248-25-8; 21529_FLUKA; HSDB 6813; 3-(hexanoyloxy)-4-(trimethylazaniumyl)butanoate; Carboxylic acids, C5-9; NSC 8266; NCIOpen2_005355; LMFA07070070; 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, chloride (1:1); EINECS 205-550-7; SCHEMBL235082; 1-Hexanoic acid; Pentanecarboxylic acid; Acid C-6; Carboxylic acids, C6-18 and C6-18-unsatd. mono- and C8-15-di-; H12137_ALDRICH; W255904_ALDRICH; 16571-42-9; Hexylic acid; AIDS212980; Caproic acid [UN2829] [Corrosive]; FEMA No. 2559; 67762-36-1; n-Hexylic acid; Hexoic acid; Pentiformic acid; EINECS 274-509-3; 6418-78-6; AIDS-212980; 53896-26-7; CTK4C6070; EINECS 271-676-4; Hexanoic acid ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; CHEBI:70749; InChI=1/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8; O-hexanoylcarnitine; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, inner salt; 3-(hexanoyloxy)-4-(trimethylammonio)butanoate | C6H12O2 | 116.158 | C(O[H])(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN042858 | Luteolin | Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone | C15H10O6 | 286.236 | c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN043865 | Isocantleyine | (6R,7R)-6-hydroxy-7-methyl-2-pyrindan-4-carboxylic acid methyl ester; 5H-2-Pyridine-4-carboxylic acid, 6,7-dihydro-6-hydroxy-7-methylmethyl ester; 143564-04-9; (6R,7R)-6-hydroxy-7-methyl-6,7-dihydro-5H-cyclopenta[d]pyridine-4-carboxylic acid methyl ester; isocantleyine; 5H-2-Pyridine-4-carboxylic acid, 6,7-dihydro-6-hydroxy-7-methyl-, methyl ester, (6R-trans)-; methyl (6R,7R)-6-hydroxy-7-methyl-6,7-dihydro-5H-cyclopenta[d]pyridine-4-carboxylate | 207.23 | ||
| TCMBANKIN058221 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN058264 | Skimmetin | Hydrangin; AI3-38054; ACon1_000219; Coumarin, 7-hydroxy-; SPBio_002083; H24003_ALDRICH; EINECS 202-240-3; CCRIS 3591; MEGxp0_000814; 7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-2-chromenone; BSPBio_002362; NSC19790; 7 HC; Spectrum2_001962; Hydrangine; NSC 19790; ST5308216; 93979_FLUKA; 5-18-01-00386 (Beilstein Handbook Reference); NCGC00095801-01; Skimmetine; BRN 0127683; SPECTRUM231084; beta-umbelliferone; 7-Hydroxycoumarin; Umbelliferon; 7-hydroxy-2H-chromen-2-one; CHEBI:27510; AIDS-005662; Umbelliferone; .beta.-Umbelliferone; Spectrum3_000751; 2H-1-Benzopyran-2-one, 7-hydroxy-; 7-Oxycoumarin; C09315; ZINC00058111; 7-hydroxychromen-2-one; NCI60_001646; 93-35-6; InChI=1/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10; SDCCGMLS-0066941.P001; AIDS005662; KBio3_001582 | C9H6O3 | 162.14 | C1=CC(=CC2=C1C=CC(=O)O2)O |
| TCMBANKIN058314 | benzaldehyde | SCHEMBL896024; A804633;Benzoic aldehyde;WLN: VHR;InChI=1/C7H6O/c8-6-7-4-2-1-3-5-7/h1-6; CHEBI:17169; Benzene methylal; B1334_ALDRICH; Ald3-H_000012; Benzenecarbonal; Benzaldehyde (natural); NCGC00091819-01; AI3-09931; EINECS 202-860-4; Oil of Bitter Almond; ST5213372; Artificial essential oil of almond; nchembio814-comp15; LS-27; EPA Pesticide Chemical Code 008601; BENZALDEHYDE; W212709_ALDRICH; Ald3.1-H_000160; D02314; Benzenemethylal; NCI-C56133; HSDB 388; 12010_FLUKA; Ald3.1-H_000479; Benzaldehyde FFC; W212717_ALDRICH; Benzene carbaldehyde; CCRIS 2376; 100-52-7; Benzaldehyde [UN1990] [Class 9]; Caswell No. 076; Benzenecarboxaldehyde; Benzoyl hydride; Ald3.1-H_000798; Benzaldehyde (NF); Artificial Almond Oil; Benzaldehyde [USAN]; Artificial Bitter Almond Oil; 09143_FLUKA; C00261; Synthetic oil of bitter almond; FEMA No. 2127; ghl.PD_Mitscher_leg0.170; c0279; 418099_ALDRICH; Benzoic aldehyde; Benzene carboxaldehyde; benzanoaldehyde; Bitter almond oil, synthetic; UN1990; NSC7917; Almond Artificial Essential Oil; NSC 7917; Benzadehyde; Phenylmethanal | C7H6O | 106.12 | C1=CC=C(C=C1)C=O |
| TCMBANKIN058643 | Coumaran | 2,3-dihydro-1-benzofuran; 37281_FLUKA; 2,3-DIHYDROBENZOFURAN; EINECS 207-817-3; Benzofuran, 2,3-dihydro-; 496-16-2; InChI=1/C8H8O/c1-2-4-8-7(3-1)5-6-9-8/h1-4H,5-6H; SB 01482; 183962_ALDRICH,Kumaran | C8H8O | 120.15 g/mol | C1COC2=CC=CC=C21 |
| TCMBANKIN058737 | Methylheptadienone | 1604-28-0; SBB008066; 2-Methylhepta-2,4-dien-6-one; (3E)-6-methylhepta-3,5-dien-2-one; AI3-25071; FEMA No. 3363; EINECS 216-507-7; W336300_ALDRICH; (3E)-6-Methyl-3,5-heptadien-2-one; ZINC02018343; 6-Methylhepta-3,5-dien-2-one; 6-Methyl-3,5-heptadiene-2-one; 3,5-Heptadien-2-one, 6-methyl-; FR-0833; 16647-04-4; 3,5-Heptadien-2-one, 6-methyl-, (E)-; 6-METHYL-3,5-HEPTADIEN-2-ONE;(e)-6-methyl-3,5-heptadien-2-one; (4E)-8-methylnona-4,7-dien-3-one; AC1NSYFD;6- Methyl- 3, 5- heptadiene-2- one;6-methyl-3,5-heptadiene-2-one;(E)-6-Methyl-3,5-heptadien-2-one | C8H12O | 124.18 g/mol | CC(=CC=CC(=O)C)C |
| TCMBANKIN059087 | Synox TBC | 4-tert-butylbenzene-1,2-diol; 23193_RIEDEL; 1,2-Dihydroxy-4-tert-butylbenzene; 4-06-00-06014 (Beilstein Handbook Reference); 4-tert-Butyl-1,2-benzenediol; 23195_RIEDEL; p-t-Butylpyrocatechol; 4-tert-Butylpyrocatechol; 4-tert-Butyl-pyrocatechol; p-tert-Butylpyrocatechol; WLN: QR BQ DX1 & 1 & 1; 23194_RIEDEL; 4-tert-Butyl-1,2-dihydroxybenzene; 4-tert-Butylcatechol solution; p-tert-Butyl catechol; 19671_FLUKA; NSC5310; AIDS-017768; 4-T-BUTYLCATECHOL; NSC 5310; 4-t-Butylpyrocatechol; CCRIS 3332; EINECS 202-653-9; AI3-24363; NCGC00091483-01; 19670_FLUKA; 4-tert-Butylcatechin; 03865_FLUKA; ZINC00388150; 4-tert-Butylpyrokatechin [Czech]; 4-TBC; NCGC00091483-02; AIDS017768; 1,2-Benzenediol, 4-(1,1-dimethylethyl)-; 98-29-3; 124249_ALDRICH; p-tert-Butylcatechol; t-Butyl catechol; Pyrocatechol, 4-tert-butyl-; 4-tert-Butylcatechol; BRN 2043335;4-[1,1-Dimethylethyl]-1,2-benzenediol | C10H14O2 | 166.22 | CC(C)(C)C1=CC(=C(C=C1)O)O |
| TCMBANKIN059531 | eucalyptol | C10H18O | 154.25 g/mol | CC1(C2CCC(O1)(CC2)C)C | |
| TCMBANKIN059532 | (1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one | C10H16O | 152.23 g/mol | CC1(C2CCC1(C(=O)C2)C)C | |
| TCMBANKIN059982 | d-limonene | C10H16 | 136.23 g/mol | CC1=CCC(CC1)C(=C)C | |
| TCMBANKIN059985 | alpha-terpinol | C10H18O | 154.25 g/mol | CC1=CCC(CC1)C(C)(C)O | |
| TCMBANKIN060145 | rhamnose | C6H12O5 | 164.16 g/mol | CC1C(C(C(C(O1)O)O)O)O | |
| TCMBANKIN060440 | pulegone | C10H16O | 152.23 g/mol | CC1CCC(=C(C)C)C(=O)C1 | |
| TCMBANKIN060895 | γ-nonalactone | C9H16O2 | 156.22 g/mol | CCCCCC1CCC(=O)O1 | |
| TCMBANKIN060994 | capraldehyde | C10H20O | 156.26 g/mol | CCCCCCCCCC=O | |
| TCMBANKIN061058 | n-hexadecane | C16H34 | 226.44 g/mol | CCCCCCCCCCCCCCCC | |
| TCMBANKIN061085 | n-heptadecane;heptadecane;Heptadekan | C17H36 | 240.5 g/mol | CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061100 | nonadecane | C19H40 | 268.5 g/mol | CCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061111 | heneicosane | C21H44 | 296.57 | CCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061161 | eicosanol;n-eicosanol | C20H42O | 298.55 | CCCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061163 | 1-NONADECANOL | C19H40O | 284.52 | CCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061164 | octadecanol | C18H38O | 270.5 g/mol | CCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061194 | 1-hexanol | C6H14O | 102.17 g/mol | CCCCCCO | |
| TCMBANKIN061399 | 4-dicaffeoylquinic acid methyl ester | 3,4-di-o-caffeoylquinicacid methyl ester; 3,4-di-O-caffeoyl quinic acid methyl ester;4,5-di-O-caffeoylquinic acid methyl ester;macranthoin f | C26H26O12 | 530.52 g/mol | COC(=O)C1(CC(C(C(C1)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O |
| TCMBANKIN061469 | isoferulic acid | 4CH-004345; KBio3_001774; NSC-51987; 4FE; Spectrum3_000887; 25522-33-2; ST098721; FCH3451845; AX8011852; 537-73-5; V0307; CHEBI:27794; Bio-0194; 3-Hydroxy-4-methoxycinnamate; KBio2_004107; CS-W020120; (E)-3'-Hydroxy-4'-methoxycinnamic acid; ZINC156055; 3-Hydroxy-4-methoxycinnamic acid; BRN 2212760; M-2347; SpecPlus_000233; 2-Propenoic acid,3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; C10470; SCHEMBL249041; N1393; 4-10-00-01777 (Beilstein Handbook Reference); QURCVMIEKCOAJU-HWKANZROSA-N; XSQ2K2G7MC; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans, 97%; EINECS 208-676-0; Spectrum4_000979; 3-(3-Hydroxy-4-methoxyphenyl)acrylic acid; NCGC00247490-01; 3-hydroxy-4-methoxy-Cinnamate; 3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid; AK676011; AM20040660; Isoferulate; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; 3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; (E)-3-(3-hydroxy-4-methoxyphenyl)acrylic acid; AC1LEHK0; PubChem8187; ST2404733; Cinnamic acid, 3-hydroxy-4-methoxy-; 2-Hydoxy-4-methoxy-5-sulfobenzophenone; KBioSS_001539; UNII-XSQ2K2G7MC; TX-011905; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans; 3-hydroxy-4-methoxy-cinnamic acid; 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Z2693271860; HMS2268G06; BG01510484; SMR001215828; GTPL7980; ST5135831; 103012_ALDRICH; BBV-025077; BDBM50241245; SC-05161; (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; AC1Q4691; MolPort-000-490-526; (E)-3-(3-hydroxy-4-methoxy-phenyl)-acrylic acid; CI-177; isoferulic acid ; KBio2_006675; AX8329161; AC1Q5T96; MFCD00004391; EINECS 247-071-6; DivK1c_006329; Q-100609; AC1Q5RAQ; FCH089654; Hesperetic acid; 537H735; KBio1_001273; KBioGR_001357; AK-88788; MLS000563054; Hesperetate; I01-2711; bmse000618; trans-Isoferulic acid, analytical standard; (2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Spectrum_001059; AKOS000141174; (E)-3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; RP25302; Cinnamic acid, 3-hydroxy-4-methoxy- (8CI); STR05122; SBB042817; Isoferulasaure; MS-11465; AB0019799; D04EWW; Isoferulic acid; 3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; 3-Hydroxy-4-methoxycinnamic-acid; (2E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid #; (E)-3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; AC1Q4690; NSC51987; AJ-13677; KBio2_001539; Hespertitinic acid; NSC 51987; DB07109; EN300-50983; SCHEMBL249042; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-; CHEMBL233295; KB-182983; 3-(3-hydroxy-4-methoxyphenyl)-2-Propenoate; MCULE-7013523945;hespereticacid | C10H10O4 | 194.18 | COC1=C(C=C(C=C1)C=CC(=O)O)O |
| TCMBANKIN061822 | 4-methoxybenzaldehyde | KS-000002NI; EC 204-602-6; anisaldehyd; 4-methoxylbenzaldehyde; SBB040224; FEMA No. 2670; DB-012818; 4-Methoxybenzaldehyde; 4-(methyloxy)benzaldehyde; A0480; MFCD00003385; CJ-01596; SC-26765; 4-Methoxybenzaldehyde, 98% 50g; bmse010130; AK-72956; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; 4-methoxybenzoyl; 4-Anisaldehyde; NCGC00257076-01; AN-22903; EBD1062; I922; P-ANISALDEHYDE; p-Anisic aldehyde; p-Methoxybenzaldehyde; Anisaldehyde; anisal; 79582-EP2305698A2; 4-methoxybenzaldehye; BG01497623; C10761; EINECS 256-891-3; DSSTox_RID_78277; Methoxybenzaldehyde (Related); EINECS 204-602-6; KB-193002; BB_NC-2206; AS02988; NSC 5590; p-Anisaldehyde, natural, 98%, FG; Benzaldehyde, 4-methoxy-; 4-Methoxy-benzaldehyde; HMS3039F08; p-Methoxybenzylidenemalonitrile; DSSTox_GSID_26997; 4-methoxybenzene carboxaldehyde; I01-0482; 123-11-5; anisic aldehyde (natural); UNII-9PA5V6656V; RP20260; AJ-14902; p-Anisaldehyde, United States Pharmacopeia (USP) Reference Standard; Q-100105; 79582-EP2292628A2; ST50213373; Anisaldehyde solution; 79582-EP2374783A1; DTXSID2026997; p-Methoxy Benzaldehyde, Natural; NCGC00090807-01; KB-115367; ZINC157146; p-Anisaldehyde, primary pharmaceutical reference standard; AI3-00223; 68894-36-0; 79582-EP2298755A1; AC-10379; AC1L1L81; CHEMBL161598; p-Anisaldehyde, for synthesis, 98.0%; 4-methoxy-benzaldehyde; LS-20018; 29578-EP2308838A1; CAS-123-11-5; SCHEMBL1100; 29578-EP2311825A1; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; SMR001224521; p-Anisaldehyde, 8CI; 29578-EP2305696A2; 4-08-00-00252 (Beilstein Handbook Reference); LS-2093; 79582-EP2305695A2; para-methoxybenzaldehyde; 26249-15-0; ZRSNZINYAWTAHE-UHFFFAOYSA-N; CHEBI:28235; NATURAL ANISIC ALDEHYDE; DSSTox_CID_6997; p-Formylanisole; Anisaldehyde; p-Anisaldehyde (4-Methoxybenzaldehyde); ACMC-1BAZN; 29578-EP2305695A2; Formylanisole, p-; WLN: VHR DO1; p-Anisaldehyde, 98%; p-Methoxybenzafdehyde; BRN 0471382; ZB006571; Caswell No. 051E; ST2411506; FT-0617622; 4-Methoxybenzaldhyde; p-Anisaldehyde, certified reference material, TraceCERT(R); KSC174M6D; 29578-EP2311842A2; NCGC00259492-01; p-Methoxybenzaldehyde (natural); p-Anisaldehyde, >=97.5%, FCC, FG; p-Methoxybenzaldehyde; Tox21_303331; 721942-53-6; p-Anisic aldehyde; 3-Chlorobenzenesulfonyl chloride, 98%; 79582-EP2305696A2; MLS002152921; RTR-003659; A805017; p-Anisaldehyde, analytical standard; 4-methoxy benzaldehyde; Anis aldehyde; para-anisaldehyde; 4-methoxybezaldehyde; HSDB 2641; 29578-EP2284160A1; PubChem22535; Aubepine; 29578-EP2305698A2; Jsp001555; I01-8766; ANW-18100; 79582-EP2305697A2; AKOS000118814; 29578-EP2292628A2; M-6033; Anisic aldehyde; CTK0H4661; BR-72956; TR-003659; TRA0080347; 79582-EP2287153A1; BBL027436; Tox21_201943; NCGC00090807-02; NSC-5590; para-methoxy benzaldehyde; Obepin; CCG-214805; MolPort-000-871-198; CS-W020189; FEMA 2670; Anisaldehyde (para); 79582-EP2377841A1; 29578-EP2305697A2; MCULE-9537754812; F2190-0575; 9PA5V6656V; p-methoxy benzaldehyde; AC1Q4CCF; NSC5590; CCRIS 821; BDBM50139370; Crategine;anisaldehyde;p-Anis aldehyde;AI3-00223; 4-Anisaldehyde; Crategine; 26249-15-0; p-Methoxybenzaldehyde (natural); EINECS 204-602-6; C10761; 19486-71-6; 68894-36-0; NSC 5590; 4-Methoxybenzaldehyde-; CCRIS 821; Aubepine; ZINC00157146; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; WLN: VHR DO1; Anisaldehyde solution; (4-METHOXYPHENYL)((2)H)FORMALDEHYDE; Benzaldehyde, 4-methoxy-; Benzaldehyde, methoxy-; ST5213373; p-Formylanisole; W267007_ALDRICH; HSDB 2641; A-d1; 4-08-00-00252 (Beilstein Handbook Reference); deuterio-(4-methoxyphenyl)methanone; Obepin; p-Anisaldehyde; Aub+ pine; NSC5590; ANISALDEHYDE; 4-Methoxybenzaldehyde; 97063_FLUKA; 123-11-5; FEMA No. 2670; p-Anisic aldehyde; Caswell No. 051E; BRN 0471382; 50984-52-6; DTXSID40460063; A88107_ALDRICH; 4-Methoxybenzaldehyde-alpha-d1, 98 atom % D; 4-Methoxybenzaldehyde-alpha-d1; p-Methoxybenzaldehyde; Formylanisole, p-; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; LS-2093; Anisic aldehyde; EINECS 256-891-3; NCGC00090807-01; Methoxybenzaldehyde; SRA1_SIAL; p-Anisaldehyde-;p-anisaldehyde | C8H8O2 | 136.15 g/mol | COC1=CC=C(C=C1)C=O |
| TCMBANKIN061880 | herniarin | 7-methoxycoumarin; 7- methoxy coumarin; Ayapanin220337_ALDRICH; NSC404559; 7-methoxychromen-2-one; DivK1c_006418; KBioGR_002056; Herniarine; KBio2_006008; KBio3_001206; 2H-1-BENZOPYRAN-2-ON; E, 7-METHOXY-; SDCCGMLS-0066524.P001; Herniarin; 531-59-9; 7-Methoxycoumarin; MEGxp0_000150; ACon1_002037; 64951_FLUKA; 7-Methoxy-2H-1-benzopyran-2-one; 5-18-01-00387 (Beilstein Handbook Reference); C09268; SPBio_000615; NSC 404559; 7-methoxy-2-chromenone; METHOXYCOURMARIN, 7-; BSPBio_001706; Spectrum_000392; KBio2_003440; KBioSS_000872; ST5406549; Spectrum3_000263; EINECS 208-513-3; Methyl umbelliferyl ether; MLS000574914; AIDS026313; SPECTRUM210874; Spectrum4_001558; Spectrum2_000398; Herniarin (6CI); KBio2_000872; SpecPlus_000322; Coumarin, 7-methoxy-; Spectrum5_000156; ZINC00391177; Coumarin, 7-methoxy- (8CI); W515809_ALDRICH; AIDS-026313; Methylumbelliferone; BRN 0141728; KBio1_001362; NCGC00095528-01; SMR000156201 | C10H8O3 | 176.17 g/mol | COC1=CC2=C(C=C1)C=CC(=O)O2 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab